{
    "body": "What is the link between TB (Turbeculosis) infection and TNFa inhibition?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/19176545", 
        "http://www.ncbi.nlm.nih.gov/pubmed/25095612", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24295645", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19075965", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19107015"
    ], 
    "ideal_answer": [
        "The occurrence of tuberculosis (TB) in patients treated with immunosuppressive drugs (ISD) is an old problem that has been highlighted by cases occurring in patients using anti-TNFalpha drugs."
    ], 
    "type": "summary", 
    "id": "58ea521d3e8b6dc87c00000f", 
    "snippets": [
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 81, 
            "text": "The use of TNFalpha blockers is associated with reactivation of tuberculosis (TB)", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25095612", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 207, 
            "text": "We present two patients with inflammatory bowel disease who, despite negative tuberculosis screening, developed a de novo tuberculosis infection after the start of anti tumor necrosis factor alpha treatment.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24295645", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 11, 
            "offsetInEndSection": 302, 
            "text": "To compare the performance of two interferon gamma release assays (IGRAs) and conventional screening tests in patients with inflammatory arthritis undergoing screening for latent tuberculosis infection (LTBI) before treatment with anti-tumour necrosis factor alpha (anti-TNFalpha) compounds.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19176545", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 192, 
            "text": "The occurrence of tuberculosis (TB) in patients treated with immunosuppressive drugs (ISD) is an old problem that has been highlighted by cases occurring in patients using anti-TNFalpha drugs.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19107015", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 198, 
            "text": "TNFalpha plays a pivotal role not only in the inflammatory process but also in the normal response against pathogens and therefore, interfering with this cytokine may increase the risk of infection.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19075965", 
            "endSection": "abstract"
        }
    ]
}